mrna
Moderna authorised to upscale development of mRNA vaccines in UK
April 15, 2025Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …
CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates
May 9, 2023Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines
CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …
Health Canada announce first full approval for Moderna COVID-19 vaccine
September 17, 2021Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna
Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …
Sanofi complete acquisition of mRNA company Translate Bio
September 15, 2021Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines
French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …
RNA breakthrough: Fluorescence used to track molecule movement
June 30, 2021Research and Development AstraZeneca, RNA, mrna
Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
Australian PM calls for domestic mRNA vaccine production
May 21, 2021Medical Communications Australia, Moderna, Vaccine, mrna
Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy
January 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Moderna Therapeutics, mrna
Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein …
AstraZeneca strikes mRNA-based partnership in respiratory disease
August 22, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Ethris, MedImmune, mrna, pharma, pharmaceuticals
AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
